Skip to main content
RecallFDAfda-F-1456-2019OTHER

Performance Mushrooms product is dried mushroom blend of 4 different mushroom mycelial biomass powders cultured on certified organic oats...

Category
Units Affected
24,862
Recall Date
May 24, 2019
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1456-2019.

The product is incorrectly labeled with 14 mg of Iron and 78% DV when the actual amount is 14 mcg of Iron and 0% DV.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1456-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Laird Superfood Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1456-2019.

LAIRD SUPERFOOD INC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Laird Superfood Inc Recall FAQ

Laird Superfood Inc is the subject of a beverages safety report: Performance Mushrooms product is dried mushroom blend of 4 different mushroom mycelial biomass powders cultured on certified organic oats.... The notice was published on May 24, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 24,862 units are potentially affected.